Case Control Study
Copyright ©The Author(s) 2024.
World J Hepatol. Apr 27, 2024; 16(4): 601-611
Published online Apr 27, 2024. doi: 10.4254/wjh.v16.i4.601
Table 1 Maternal and fetal clinical characteristics of patients with intrahepatic cholestasis of pregnancy and normal pregnant group, mean ± SD
Index
NP (n = 30)
ICP (n = 34)
P value
Baseline informationMaternal fundal height (cm)34.60 ± 2.4332.79 ± 3.190.014
Maternal abdominal circumference (cm)102.17 ± 5.8997.47 ± 8.730.016
Blood routineHemoglobin (g/L)4.20 ± 0.603.79 ± 0.440.003
Hematocrit127.33 ± 12.14117.41 ± 12.320.002
Leukocyte (× 109/L)10.70 ± 3.238.10 ± 2.34< 0.001
Percentage of neutrophils (%)77.96 ± 6.6972.50 ± 8.860.008
Liver functionDirect bilirubin (μmol/L)1.45 ± 0.732.37 ± 2.090.018
Glutamic-pyruvic transaminase (U/L)9.40 ± 3.1938.33 ± 48.76< 0.001
Total bile acid (μmol/L)2.65 ± 1.3522.64 ± 18.11< 0.001
Cholyglycine (mg/L)1.38 ± 0.186.58 ± 8.92< 0.001
Fetal ultrasoundBiparietal diameter (mm)93.40 ± 3.5691.49 ± 4.090.032
Fetal head circumference (mm)334.40 ± 11.03327.86 ± 12.400.029
Fetal abdominal circumference (mm)337.20 ± 19.36326.57 ± 18.670.028
Fetal femur length (mm)71.47 ± 3.4768.89 ± 3.870.007
Pregnancy outcomeGestational week of delivery (wk)39.39 ± 0.8437.82 ± 1.64< 0.001
Vaginal delivery [n (%)]23(76.67)11(32.35)< 0.001
Neonatal birth weight (g)3476.00 ± 436.123063.14 ± 386.62< 0.001
Table 2 Pearson’s correlation between maternal serum short-chain fatty acids and cord blood short-chain fatty acids
ALL
NP
ICP
r (Pearson)
P value
r (Pearson)
P value
r (Pearson)
P value
Acetic acid0.330.030.030.90 -0.240.45
Propionic acid9.42E-041.00 0.020.93-0.120.70
Isobutyric acid-0.210.190.210.35-0.170.61
Butyric acid0.110.480.050.820.350.26
Isovaleric acid0.050.76-0.120.590.040.89
Valeric acid-0.170.29-0.230.30 -0.030.92
Caproic acid0.380.010.220.330.180.58